Viewing Study NCT03709316


Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT03709316
Status: UNKNOWN
Last Update Posted: 2021-06-02
First Post: 2018-09-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module